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Little has been recently published about speciﬁc postoperative complications following thoracic surgery in the morbidly obese pa-
tient. Greater numbers of patients who are obese, morbidly obese, or supermorbidly obese are undergoing surgical procedures.
Postoperative complications after thoracic surgery in these patients that can lead to increased morbidity and mortality, prolonged
hospital stay, and increased cost of care are considered. Complications include diﬃculties with mask ventilation and securing the
airway, obstructive sleep apnea with risk of oversedation, pulmonary complications related to reduced total lung capacity, redu-
ced functional residual capacity, and reduced vital capacity, risks of aspiration pneumonitis and ventilator-associated pneumonia,
cardiomyopathies, and atrial ﬁbrillation, inadequate diabetes management, positioning injuries, increased risk of venous throm-
bosis,andpulmonaryembolism.Thetypeofthoracicsurgicalproceduremayalsoposeotherproblemstoconsiderduringthepost-
operative period. Obese patients undergoing thoracic surgery pose a challenge to those caring for them. Those working with these
patients must understand how to recognize, prevent, and manage these postoperative complications.
1.Introduction
Little has been recently published about speciﬁc postopera-
tivecomplicationsfollowingthoracicsurgeryinthemorbidly
obese patient. Anesthesia and postoperative management of
morbidly obese patients in thoracic surgery are based on
experience in these patients undergoing other types of pro-
cedures [1]. While approximately 5% of patients undergoing
surgical procedures are considered morbidly obese (BMI >
40kg/m2), another 30% of patients in the US are considered
obese (BMI > 30kg/m2)[ 2]. The exact number of these who
require thoracic surgery is unknown. However, considering
that postoperative complications are a major cause of mor-
bidity, mortality, prolonged hospital stay, and increased cost
of care, it is important that those working with these patients
during the postoperative period understand how to recog-
nize, prevent, and manage these complications [3].
2. AirwayComplications
Mask ventilation and intubation may be diﬃcult in the mor-
bidly obese patient secondary to excessive tissue in the pos-
terior pharyngeal wall [4]. A Mallampati score of III or IV
and increased neck circumference have been found to be the
bestpredictorsofpotentialdiﬃcultywithtrachealintubation
[5]. These considerations should be kept in mind whenplan-
ning extubation following thoracic surgery in the morbidly
obese patient, whether using a double-lumen tube or a sin-
gle-lumen endotracheal tube with a bronchial blocker. The
extubation plan should consider the initial ease of mask ven-
tilation, the diﬃculty of intubation (should reintubation
become necessary), and the type of procedure performed. In
a comparison between transmediastinal and transthoracic
esophagectomy, Bartels et al. found that early extubation
(within 6 hours) following transthoracic esophagectomy
p r o l o n g sI C Ul e n g t ho fs t a ya n dl e a d st oa ni n c r e a s er a t eo f
mortality [6], although the recent trend to extubate imme-
diately after resection in the operating room has been shown
to be equally safe. When comparing early extubation in the
operating room to late extubation in the ICU, Lanuti et al.
foundthatoperativeapproachdidnotinﬂuencethefailureto
extubate [7]. Positioning morbidly obese patients in reverse
Trendelenburg has been suggested to optimize ventilation
and access to the airway should the need for reintubation
occur [1].2 Anesthesiology Research and Practice
3.ObstructiveSleep Apnea
Although most morbidly obese patients have probably not
had previous sleep studies to prove the existence of obstruc-
tive sleep apnea, many may actually have this disease. The
American Society of Anesthesiologists Task Force on Peri-
operative Management Practice Guidelines for the perioper-
ative management of patients with obstructive sleep apnea
warns that judicious use of sedatives and opiates in the peri-
operative period is indicated in patients with obstructive
sleep apnea [8]. It is probably wise to consider judicious use
of sedatives and opiates in all morbidly obese patients to
prevent oversedation and delayed airway obstruction. Non-
steroidal analgesics may reduce the need for opiates in the
postoperative period [9].
4. Pulmonary Complications
Morbidly obese patients have reduced total lung capacity,
reduced functional residual capacity, and reduced vital capa-
city [10]. Alveolar arterial oxygenation gradient is increased,
and atelectasis has been found to persist for at least 24 hours
in morbidly obese patients, whereas it disappeared in the
nonobese [11]. Consideration should be given to the increa-
sed likelihood of pulmonary complications in these patients
postoperatively. Complications related to residual atelectasis
may result in desaturation. Pneumonia, bronchospasm, atel-
ectasis,acuterespiratoryinsuﬃciency,prolongedventilation,
and bronchial infections were found in 33.9% of patients
with mild to moderate COPD undergoing general surgery.
Risk factors for increased pulmonary complications were
male gender, amount of smoking, duration of surgery over
270 minutes, low FEV1/FVC ratio, and chest or upper abdo-
minal incision [12]. A study of 147 lobectomies, comparing
VATS versus open thoracotomy, found that VATS patients,
in spite of having more comorbidities, had signiﬁcantly less
postoperative pneumonia, fewer chest tube days, and a shor-
ter hospital length of stay [13].
Ventilator-associated pneumonia can be a life-threaten-
ing complication in the course of 8–28% of mechanically
ventilated patients. Mortality rates range between 24 to 50%
and can be as high as 76%, when lung infection is with
high-risk pathogens [14]. Several studies have shown that
prompt diagnosis and appropriate antimicrobial treatment
result in signiﬁcantly improved outcomes. Important clinical
goals are more rapid identiﬁcation of aﬀected patients and
accurate selection of antibiotics [15–17].
Aspiration pneumonitis following regurgitation of gas-
tric contents under general anesthesia, although rare, occur-
ring approximately 1 in every 3,000 general anesthetics, can
result in devastating consequences. The mortality rate fol-
lowing aspiration of gastric contents is 1 in 71,000 general
anesthetics [18]. Obese patients have typically been consid-
ered to have high-volume, low pH gastric contents that may
lead to increased risk of aspiration pneumonitis, although
these ﬁndings have not been conﬁrmed in more recent stud-
ies [19–21].
Pulmonary function can be improved in intubated pa-
tients by applying CPAP or PEEP to help avoid atelectasis,
improve oxygenation, and reduce CO2 [3]. BiPAP has
been shown to signiﬁcantly reduce pulmonary dysfunction
following gastroplasty in obese patients and accelerates re-
establishment of preoperative pulmonary function [22]. It
would seem likely that this may be beneﬁcial in morbidly
obese patients following thoracic surgery as well. Thoracic
epidural analgesia has been shown to signiﬁcantly improve
vital capacity in obese patients following midline laparotomy
surgery over intravenous opioid analgesia alone and should
be considered [23]. Della Rocca et al. reported thoracic epi-
durals to be superior to IV morphine in terms of analgesia,
hospitallengthofstay,andpostoperativecomplications,such
as nausea and vomiting [24]. Paravertebral blocks have been
shown to be superior in thoracotomies to thoracic epidural,
with fewer complications, such as hypotension and postop-
erative nausea and vomiting. Although regional techniques
of any kind may pose signiﬁcant challenges in the morbidly
obese, consideration should be given to improve postop-
erative pulmonary function and reduce complications. Of
note, contraindications to thoracic epidural placement do
not preclude paravertebral blocks as there appears to be a
decreased risk of neurological injury [25]. Dexmedetomi-
dine, an alpha 2 agonist with properties that have minimal
eﬀects on respiration, may be useful in these patients [26].
5. CardiacComplications
Right ventricular dysfunction can be demonstrated by echo-
cardiography in many obese patients, even if asymptomatic
[27]. A great risk of pulmonary and systemic hypertension,
relatedtoincreasedbloodvolumeandhighercardiacoutput,
may exist in morbidly obese patients. Obesity cardiomyopa-
thy with left- and right-heart failure secondary to eccentric
right and left ventricular hypertrophy may result if these are
present for a long period of time. The risk may be increased
inthepresenceoflong-standingobstructivesleepapnea[28].
Atrial ﬁbrillation is a common complication in the obese
patient, with risk increasing 4% per 1-unit increase in BMI
[29]. In a study of 2588 patients undergoing noncardiac
thoracic surgery, patients who developed atrial ﬁbrillation
had increased mean lengths of stay, higher mortality rates,
andgreatermeanhospitalcharges.Signiﬁcantvariablesasso-
ciated with increased occurrence of atrial ﬁbrillation were
male sex, age, history of congestive heart failure, history of
arrhythmias, history of peripheral vascular disease, resection
of mediastinal tumor, lobectomy, bilobectomy, pneumonec-
tomy, esophagectomy, and intraoperative transfusions [30].
Therapies targeted to reduce the incidence of atrial ﬁbrilla-
tion in morbidly obese patients undergoing thoracic surgery
seem warranted.
6. Other Postoperative Complications
The risk of thromboembolism is thought to be greater in
morbidly obese patients [31]. Deep venous thrombosis and
skin ulcerations are common in the morbidly obese patient.
Varicoseveinsmayoccur,andlymphoedemamayresult[32].
Pulmonary embolism is a real risk for these patients, espe-
cially those with decreased mobility [33]. Morbidly obeseAnesthesiology Research and Practice 3
patients have been shown to have a greater incidence of post-
operative complications than normal-weight patients under-
going cardiac surgery [34]. Meticulous venous thromboem-
bolism prophylaxis is necessary to decrease the incidence of
these complications.
There is a strong correlation between obesity and dia-
betes mellitus (DM), type 2, in all ethnic populations. Obe-
sity is attributed to be the cause in more than 80% of Type 2
DM [32]. Morbidly obese patients have a higher incidence
of DM as the degree and duration of obesity, as well as
distribution of body fat, increase the risk [35]. Close mon-
itoring of postoperative glucose levels is recommended.
Although no studies have suggested a target glucose level
postoperativelyinpatientswhohaveundergonethoracicsur-
gery, poor intraoperative control of glucose levels in patients
undergoing cardiac surgery has been shown to worsen hos-
pital outcomes [36]. However, a recently reported clinical
trial of intensive insulin therapy (ACCORD) found a 3- to
4-fold increase in hypoglycemia which was associated with
excessmortality.Therisksincreasedinolderpatients,coexis-
tingseverecomorbidities,thepresenceofundiagnosedhypo-
glycemia, and the duration of diabetes and insulin therapy
[37, 38]. It is likely that in morbidly obese patients with
coexisting type 2 DM undergoing thoracic surgery the same
outcomes may be expected. A recommended target mini-
mum glucose level of 200mg/dL has been suggested [35].
The changes in pharmacokinetics and pharmacodyna-
mics caused by obesity provide further challenges in postop-
erative management of the morbidly obese patient. Organs
involvedindrugelimination(liver,kidney,etc.)maybeaﬀec-
ted, and drug administration is diﬃcult, as most recommen-
ded doses are based on data obtained from individuals with
normalweight.Useoftotalbodyweightinsteadofidealbody
weight may result in an inadvertent overdose. Respiratory
depression from excessive opioids has been previously dis-
cussed. Residual neuromuscular blockade from inappropri-
ate dosing can be lethal. Reversal of neuromuscular blockade
with neostigmine has been suggested in all morbidly obese
patients, and close monitoring following extubation in the
postanesthesia care unit is necessary [39].
Complications following anesthesia for thoracic surgery
in morbidly obese patients may also include the same as
for other patients, such as nerve injury due to inadequate
padding and inappropriate positioning, perioperative myo-
cardial ischemia or infarction, or untoward neurologic sequ-
e l a e ,s u c ha ss t r o k e .
7. Conclusion
Althoughlittlehasbeenpublishedspeciﬁcallyrelatedtomor-
bidly obese patients undergoing thoracic surgery, the risk of
postoperative complications is high, which can result in in-
creased morbidity and mortality, increased length of stay,
and increased costs of care. Anesthesia providers must be
aware of these complications to prevent and manage these
patients in the postoperative period. Clinical outcome stud-
ies speciﬁcally related to the morbidly obese patients are still
lacking.
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